Propanc Biopharma (PPCB) vs Redhill Biopharma (RDHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Propanc Biopharma is the larger company by market cap ($4.9 million vs $4.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | PPCB | RDHL |
|---|---|---|
| Share price | $0.4987 | $0.474 |
| Market cap | $4.90M | $4.21M |
| 1-day change | +1.51% | -2.07% |
| Forward P/E | — | 15.80 |
| EPS (TTM) | $-17.62 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.75 | $2.14 |
| 52-week low | $0.46 | $0.465 |
| Distance from 52-week high | -98.98% | -77.85% |
| Average volume | 1.79M | 1.81M |
| Shares outstanding | 9.83M | 8.89M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
PPCB vs RDHL FAQ
Which is bigger, Propanc Biopharma or Redhill Biopharma?
Propanc Biopharma (PPCB) is larger, with a market capitalization of $4.90M compared with $4.21M for Redhill Biopharma (RDHL).
Are Propanc Biopharma and Redhill Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.